{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:07:00Z","timestamp":1785582420650,"version":"3.56.0"},"reference-count":160,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Canadian Institutes of Health Research","award":["HB2-164064"],"award-info":[{"award-number":["HB2-164064"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>There is currently no cure for HIV infection although adherence to effective antiretroviral therapy (ART) suppresses replication of the virus in blood, increases CD4+ T-cell counts, reverses immunodeficiency, and increases life expectancy. Despite these substantial advances, ART is a lifelong treatment for people with HIV (PWH) and upon cessation or interruption, the virus quickly rebounds in plasma and anatomic sites, including the central nervous system (CNS), resulting in disease progression. With recent advances in quantifying viral burden, detection of genetically intact viral genomes, and isolation of replication-competent virus from brain tissues of PWH receiving ART, it has become apparent that the CNS viral reservoir (largely comprised of macrophage type cells) poses a substantial challenge for HIV cure strategies. Other obstacles impacting the curing of HIV include ageing populations, substance use, comorbidities, limited antiretroviral drug efficacy in CNS cells, and ART-associated neurotoxicity. Herein, we review recent findings, including studies of the proviral integration sites, reservoir decay rates, and new treatment\/prevention strategies in the context of the CNS, together with highlighting the next steps for investigations of the CNS as a viral reservoir.<\/jats:p>","DOI":"10.3390\/v15122385","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T08:09:17Z","timestamp":1701763757000},"page":"2385","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Is the Central Nervous System Reservoir a Hurdle for an HIV Cure?"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9342-6227","authenticated-orcid":false,"given":"Nazanin","family":"Mohammadzadeh","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB T6G 2R3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9747-5018","authenticated-orcid":false,"given":"Nicolas","family":"Chomont","sequence":"additional","affiliation":[{"name":"Department of Immunopathology, Research Centre of the Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CRCHUM), Montreal, QC H2X 0A9, Canada"},{"name":"Department of Microbiology, Infectiology and Immunology, Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, QC H3C 3J7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Estaquier","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Center, Qu\u00e9bec, QC G1V 4G2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1269-3791","authenticated-orcid":false,"given":"Eric A.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Infectiology and Immunology, Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, QC H3C 3J7, Canada"},{"name":"Institut de Recherches Cliniques de Montreal, Montreal, QC H2W 1R7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Power","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB T6G 2R3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"key":"ref_1","unstructured":"(2021, September 28). HIV\/AIDS. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","article-title":"HIV-Associated Neurocognitive Disorder--Pathogenesis and Prospects for Treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41582-023-00813-2","article-title":"Cognitive Impairment in People Living with HIV: Consensus Recommendations for a New Approach","volume":"19","author":"Nightingale","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"ref_4","unstructured":"WHO WHO UNAIDS (2013). Global Update on HIV Treatmnt 2013: Results, Impact and Opportunities, WHO."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"S\u00e1ez-Ciri\u00f3n, A., Bacchus, C., Hocqueloux, L., Avettand-Fenoel, V., Girault, I., Lecuroux, C., Potard, V., Versmisse, P., Melard, A., and Prazuck, T. (2013). Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003211"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","article-title":"Presence of an Inducible HIV-1 Latent Reservoir during Highly Active Antiretroviral Therapy","volume":"94","author":"Chun","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev.med.53.082901.104024","article-title":"The Challenge of Viral Reservoirs in HIV-1 Infection","volume":"53","author":"Blankson","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1172\/JCI134815","article-title":"HIV Persists throughout Deep Tissues with Repopulation from Multiple Anatomical Sources","volume":"130","author":"Chaillon","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/COH.0000000000000293","article-title":"Tissue Reservoirs of HIV","volume":"11","author":"Wong","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"113053","DOI":"10.1016\/j.celrep.2023.113053","article-title":"Near Full-Length HIV Sequencing in Multiple Tissues Collected Postmortem Reveals Shared Clonal Expansions across Distinct Reservoirs during ART","volume":"42","author":"Dufour","year":"2023","journal-title":"Cell Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jis326","article-title":"Central Nervous System Viral Invasion and Inflammation During Acute HIV Infection","volume":"206","author":"Valcour","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1994.tb38895.x","article-title":"Neuropathologic Aspects of Lentiviral Infections","volume":"724","author":"Georgsson","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm0197-42","article-title":"Transcytosis of Infectious Human Immunodeficiency Virus across a Tight Human Epithelial Cell Line Barrier","volume":"3","author":"Bomsel","year":"1997","journal-title":"Nat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1128\/JVI.76.13.6689-6700.2002","article-title":"Human Immunodeficiency Virus Type 1 Enters Brain Microvascular Endothelia by Macropinocytosis Dependent on Lipid Rafts and the Mitogen-Activated Protein Kinase Signaling Pathway","volume":"76","author":"Liu","year":"2002","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e1159276","DOI":"10.1080\/21688370.2016.1159276","article-title":"Human Immunodeficiency Virus-Associated Disruption of Mucosal Barriers and Its Role in HIV Transmission and Pathogenesis of HIV\/AIDS Disease","volume":"4","author":"Tugizov","year":"2016","journal-title":"Tissue Barriers"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nri1527","article-title":"The Neuropathogenesis of AIDS","volume":"5","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e03633-20","DOI":"10.1128\/mBio.03633-20","article-title":"Central Nervous System (CNS) Viral Seeding by Mature Monocytes and Potential Therapies To Reduce CNS Viral Reservoirs in the cART Era","volume":"12","author":"Veenstra","year":"2021","journal-title":"mBio"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.20411\/pai.v7i2.524","article-title":"HIV-1 Is Transported into the Central Nervous System by Trafficking Infected Cells","volume":"7","author":"Kincer","year":"2022","journal-title":"Pathog. Immun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e02784-21","DOI":"10.1128\/mBio.02784-21","article-title":"Lentiviral Infections Persist in Brain despite Effective Antiretroviral Therapy and Neuroimmune Activation","volume":"12","author":"Mohammadzadeh","year":"2021","journal-title":"mBio"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-444-63849-6.00007-4","article-title":"Chapter 7\u2014HIV-Associated Neurocognitive Disorder","volume":"Volume 152","author":"Brew","year":"2018","journal-title":"Handbook of Clinical Neurology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-Associated Neurocognitive Disorders Persist in the Era of Potent Antiretroviral Therapy: CHARTER Study","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"814362","DOI":"10.3389\/fpsyt.2022.814362","article-title":"Worldwide Prevalence of HIV Associated Neurocognitive Disorders (HAND) and Its Associated Factors: A Systematic Review and Meta-Analysis","volume":"13","author":"Zenebe","year":"2022","journal-title":"Front. Psychiatry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1473-3099(13)70269-X","article-title":"HIV-Associated Neurocognitive Disorder (HAND)","volume":"13","author":"Clifford","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/ana.410290613","article-title":"Neocortical Damage during HIV Infection","volume":"29","author":"Wiley","year":"1991","journal-title":"Ann. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00005072-199211000-00003","article-title":"Selective Neuronal Vulnerability in HIV Encephalitis","volume":"51","author":"Masliah","year":"1992","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s004010050601","article-title":"Cerebral White Matter Damage in HIV Infection Demonstrated Using Beta-Amyloid Precursor Protein Immunoreactivity","volume":"93","author":"Raja","year":"1997","journal-title":"Acta Neuropathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s13365-022-01051-w","article-title":"HIV Peripheral Neuropathy-Related Degeneration of White Matter Tracts to Sensorimotor Cortex","volume":"28","author":"Timtim","year":"2022","journal-title":"J. Neurovirol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2012.04.001","article-title":"Accumulation of Nuclear and Mitochondrial DNA Damage in the Frontal Cortex Cells of Patients with HIV-Associated Neurocognitive Disorders","volume":"1458","author":"Zhang","year":"2012","journal-title":"Brain Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Khodr, C.E., Chen, L., Al-Harthi, L., and Hu, X.-T. (2022). HIV-Induced Hyperactivity of Striatal Neurons Is Associated with Dysfunction of Voltage-Gated Calcium and Potassium Channels at Middle Age. Membranes, 12.","DOI":"10.3390\/membranes12080737"},{"key":"ref_30","unstructured":"Mitra, P., and Sharman, T. (2023). StatPearls [Internet], StatPearls Publishing."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF03256266","article-title":"NeuroAIDS: Characteristics and Diagnosis of the Neurological Complications of AIDS","volume":"12","author":"Minagar","year":"2008","journal-title":"Mol. Diagn. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/753312762","article-title":"Comparative Neurovirulence in Lentiviral Infections: The Roles of Viral Molecular Diversity and Select Proteases","volume":"10","author":"Power","year":"2004","journal-title":"J. Neurovirol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3389\/fimmu.2018.00698","article-title":"Microglia and Beyond: Innate Immune Cells As Regulators of Brain Development and Behavioral Function","volume":"9","author":"Lenz","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1017\/S1740925X12000063","article-title":"Functions of Microglia in the Central Nervous System--beyond the Immune Response","volume":"7","author":"Wake","year":"2011","journal-title":"Neuron Glia Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3389\/fncel.2018.00488","article-title":"Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response","volume":"12","author":"Bachiller","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1742-4690-7-33","article-title":"The Macrophage in HIV-1 Infection: From Activation to Deactivation?","volume":"7","author":"Herbein","year":"2010","journal-title":"Retrovirology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.virol.2006.02.031","article-title":"Macrophage Activation and Human Immunodeficiency Virus Infection: HIV Replication Directs Macrophages towards a pro-Inflammatory Phenotype While Previous Activation Modulates Macrophage Susceptibility to Infection and Viral Production","volume":"349","author":"Porcheray","year":"2006","journal-title":"Virology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e01659-19","DOI":"10.1128\/mBio.01659-19","article-title":"Myeloid and CD4 T Cells Comprise the Latent Reservoir in Antiretroviral Therapy-Suppressed SIVmac251-Infected Macaques","volume":"10","author":"Abreu","year":"2019","journal-title":"mBio"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1097\/QAD.0000000000002269","article-title":"Brain Macrophages Harbor Latent, Infectious SIV","volume":"33","author":"Abreu","year":"2019","journal-title":"AIDS"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3390\/v6041837","article-title":"HIV-1 Latency in Monocytes\/Macrophages","volume":"6","author":"Kumar","year":"2014","journal-title":"Viruses"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1742-4690-7-32","article-title":"Molecular Mechanisms of HIV-1 Persistence in the Monocyte-Macrophage Lineage","volume":"7","author":"Herbein","year":"2010","journal-title":"Retrovirology"},{"key":"ref_42","first-page":"260","article-title":"Rebound HIV-1 in Cerebrospinal Fluid after Antiviral Therapy Interruption Is Mainly Clonally Amplified R5 T Cell-Tropic Virus","volume":"8","author":"Kincer","year":"2023","journal-title":"Nat. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Lutgen, V., Narasipura, S.D., Barbian, H.J., Richards, M., Wallace, J., Razmpour, R., Buzhdygan, T., Ramirez, S.H., Prevedel, L., and Eugenin, E.A. (2020). HIV Infects Astrocytes in Vivo and Egresses from the Brain to the Periphery. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008381"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s13365-014-0304-0","article-title":"Cell-Cell Contact Viral Transfer Contributes to HIV Infection and Persistence in Astrocytes","volume":"21","author":"Luo","year":"2015","journal-title":"J. Neurovirol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/1570162033485122","article-title":"Astrocyte Infection by HIV-1: Mechanisms of Restricted Virus Replication, and Role in the Pathogenesis of HIV-1-Associated Dementia","volume":"1","author":"Gorry","year":"2003","journal-title":"Curr. HIV Res."},{"key":"ref_46","unstructured":"(2021, September 28). Secretion of Neurotoxins by Mononuclear Phagocytes Infected with HIV-1. Available online: https:\/\/www-science-org.login.ezproxy.library.ualberta.ca\/doi\/abs\/10.1126\/science.2148832."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2362.2006.01657.x","article-title":"Role of the Pro-Inflammatory Cytokines TNF-Alpha and IL-1beta in HIV-Associated Dementia","volume":"36","author":"Brabers","year":"2006","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/ana.410310402","article-title":"Cytokine Expression in the Brain during the Acquired Immunodeficiency Syndrome","volume":"31","author":"Tyor","year":"1992","journal-title":"Ann. Neurol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.aids.0000432467.54003.f7","article-title":"Increased Microglia Activation in Neurologically Asymptomatic HIV-Infected Patients Receiving Effective ART","volume":"28","author":"Garvey","year":"2014","journal-title":"AIDS"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.wnn.0000213916.10514.57","article-title":"Markers of Macrophage Activation and Axonal Injury Are Associated with Prospective Memory in HIV-1 Disease","volume":"19","author":"Woods","year":"2006","journal-title":"Cogn. Behav. Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/13550280490279807","article-title":"Expression of Chemokines by Human Fetal Microglia after Treatment with the Human Immunodeficiency Virus Type 1 Protein Tat","volume":"10","author":"Yu","year":"2004","journal-title":"J. Neurovirol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1523\/JNEUROSCI.3045-16.2017","article-title":"HIV-1 Tat Primes and Activates Microglial NLRP3 Inflammasome-Mediated Neuroinflammation","volume":"37","author":"Chivero","year":"2017","journal-title":"J. Neurosci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/glia.21171","article-title":"HIV-1 Gp120 Enhances Outward Potassium Current via CXCR4 and cAMP-Dependent Protein Kinase A Signaling in Cultured Rat Microglia","volume":"59","author":"Xu","year":"2011","journal-title":"Glia"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11481-016-9708-3","article-title":"HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: Implications for HIV-1 Associated Neuroinflammation","volume":"12","author":"Mamik","year":"2017","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s11481-020-09964-1","article-title":"Emerging Role of Nef in the Development of HIV Associated Neurological Disorders","volume":"16","author":"Yarandi","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1523\/JNEUROSCI.19-01-00064.1999","article-title":"Mechanisms and Structural Determinants of HIV-1 Coat Protein, Gp41-Induced Neurotoxicity","volume":"19","author":"Adamson","year":"1999","journal-title":"J. Neurosci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s13365-012-0091-4","article-title":"Cytokine Levels in CSF and Neuropsychological Performance in HIV Patients","volume":"18","author":"Nolting","year":"2012","journal-title":"J. Neurovirol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s11481-016-9660-2","article-title":"Chemokine CCL2 Enhances NMDA Receptor-Mediated Excitatory Postsynaptic Current in Rat Hippocampal Slices-a Potential Mechanism for HIV-1-Associated Neuropathy?","volume":"11","author":"Zhou","year":"2016","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s13365-016-0505-9","article-title":"Cerebrospinal Fluid Biomarkers and HIV-Associated Neurocognitive Disorders in HIV- Infected Individuals in Rakai, Uganda","volume":"23","author":"Abassi","year":"2017","journal-title":"J. Neurovirol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neulet.2010.09.019","article-title":"HIV Tat Elicits Microglial Glutamate Release: Role of NAPDH Oxidase and the Cystine-Glutamate Antiporter","volume":"485","author":"Gupta","year":"2010","journal-title":"Neurosci. Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1172\/JCI116518","article-title":"Quantitation of Human Immunodeficiency Virus, Immune Activation Factors, and Quinolinic Acid in AIDS Brains","volume":"91","author":"Achim","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/nn1127","article-title":"HIV-Induced Metalloproteinase Processing of the Chemokine Stromal Cell Derived Factor-1 Causes Neurodegeneration","volume":"6","author":"Zhang","year":"2003","journal-title":"Nat. Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/NDT.S232836","article-title":"The Role of Brain Derived Neurotrophic Factor in HIV-Associated Neurocognitive Disorder: From the Bench-Top to the Bedside","volume":"16","author":"Michael","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4161\/auto.6805","article-title":"Decreased Neuronal Autophagy in HIV Dementia: A Mechanism of Indirect Neurotoxicity","volume":"4","author":"Alirezaei","year":"2008","journal-title":"Autophagy"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1073\/pnas.92.16.7162","article-title":"Apoptosis and Necrosis: Two Distinct Events Induced, Respectively, by Mild and Intense Insults with N-Methyl-D-Aspartate or Nitric Oxide\/Superoxide in Cortical Cell Cultures","volume":"92","author":"Bonfoco","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3389\/fimmu.2020.01024","article-title":"Interaction of Microglia and Astrocytes in the Neurovascular Unit","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less. AIDS Clinical Trials Group 320 Study Team","volume":"337","author":"Hammer","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_68","first-page":"1","article-title":"Surveillance for AIDS-Defining Opportunistic Illnesses, 1992\u20131997","volume":"48","author":"Jones","year":"1999","journal-title":"MMWR CDC Surveill. Summ."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/hiv.12421","article-title":"Life Expectancy of HIV-Positive People after Starting Combination Antiretroviral Therapy: A Meta-Analysis","volume":"18","author":"Teeraananchai","year":"2017","journal-title":"HIV Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11481-019-09886-7","article-title":"CNS Neurotoxicity of Antiretrovirals","volume":"16","author":"Lanman","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s13365-020-00870-z","article-title":"Lifetime Antiretroviral Exposure and Neurocognitive Impairment in HIV","volume":"26","author":"Amusan","year":"2020","journal-title":"J. Neurovirol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s13365-020-00874-9","article-title":"A Review of the Potential Mechanisms of Neuronal Toxicity Associated with Antiretroviral Drugs","volume":"26","author":"Trunfio","year":"2020","journal-title":"J. Neurovirol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","article-title":"HIV-Associated Neurocognitive Disorders before and during the Era of Combination Antiretroviral Therapy: Differences in Rates, Nature, and Predictors","volume":"17","author":"Heaton","year":"2011","journal-title":"J. Neurovirol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s11904-015-0266-8","article-title":"Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered","volume":"12","author":"Gelman","year":"2015","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cid\/ciu862","article-title":"Neurocognitive Change in the Era of HIV Combination Antiretroviral Therapy: The Longitudinal CHARTER Study","volume":"60","author":"Heaton","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_77","first-page":"2290","article-title":"The Burden of HIV-Associated Neurocognitive Disorder (HAND) in Post-HAART Era: A Multidisciplinary Review of the Literature","volume":"21","author":"Caruana","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm.4411","article-title":"Defining Total-Body AIDS-Virus Burden with Implications for Curative Strategies","volume":"23","author":"Estes","year":"2017","journal-title":"Nat. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1128\/JVI.00674-16","article-title":"HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads","volume":"90","author":"Lamers","year":"2016","journal-title":"J. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e01186-17","DOI":"10.1128\/mBio.01186-17","article-title":"Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: A Functional Latent Reservoir","volume":"8","author":"Avalos","year":"2017","journal-title":"mBio"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/infdis\/jiaa532","article-title":"Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy","volume":"223","author":"Gandhi","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Gabuzda, D., Yin, J., Misra, V., Chettimada, S., and Gelman, B.B. (2023). Intact Proviral DNA Analysis of the Brain Viral Reservoir and Relationship to Neuroinflammation in People with HIV on Suppressive Antiretroviral Therapy. Viruses, 15.","DOI":"10.3390\/v15041009"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.26456","article-title":"Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART","volume":"92","author":"Cochrane","year":"2022","journal-title":"Ann. Neurol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/ana.26750","article-title":"Regional Analysis of Intact and Defective HIV Proviruses in the Brain of Viremic and Virally Suppressed People with HIV","volume":"94","author":"Angelovich","year":"2023","journal-title":"Ann. Neurol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1086\/606117","article-title":"Multidrug-Resistant Variants of HIV Type 1 (HIV-1) Can Exist in Cells as Defective Quasispecies and Be Rescued by Superinfection with Other Defective HIV-1 Variants","volume":"200","author":"Quan","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.micinf.2008.01.012","article-title":"Superinfection of Defective Human Immunodeficiency Virus Type 1 with Different Subtypes of Wild-Type Virus Efficiently Produces Infectious Variants with the Initial Viral Phenotypes by Complementation Followed by Recombination","volume":"10","author":"Iwabu","year":"2008","journal-title":"Microbes Infect."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/QAD.0000000000001267","article-title":"Reactivation of Simian Immunodeficiency Virus Reservoirs in the Brain of Virally Suppressed Macaques","volume":"31","author":"Gama","year":"2017","journal-title":"AIDS"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e167417","DOI":"10.1172\/JCI167417","article-title":"Brain Microglia Serve as a Persistent HIV Reservoir despite Durable Antiretroviral Therapy","volume":"133","author":"Tang","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cell.2021.12.011","article-title":"Parallel Analysis of Transcription, Integration, and Sequence of Single HIV-1 Proviruses","volume":"185","author":"Einkauf","year":"2022","journal-title":"Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e20211427","DOI":"10.1084\/jem.20211427","article-title":"Integration Features of Intact Latent HIV-1 in CD4+ T Cell Clones Contribute to Viral Persistence","volume":"218","author":"Huang","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41586-020-2651-8","article-title":"Distinct Viral Reservoirs in Individuals with Spontaneous Control of HIV-1","volume":"585","author":"Jiang","year":"2020","journal-title":"Nature"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ebiom.2019.06.020","article-title":"Deep Latency: A New Insight into a Functional HIV Cure","volume":"45","author":"Elsheikh","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e132997","DOI":"10.1172\/jci.insight.132997","article-title":"Differential Decay of Intact and Defective Proviral DNA in HIV-1-Infected Individuals on Suppressive Antiretroviral Therapy","volume":"5","author":"Peluso","year":"2020","journal-title":"JCI Insight"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1074\/jbc.M102671200","article-title":"Productive HIV-1 Infection of Primary CD4+ T Cells Induces Mitochondrial Membrane Permeabilization Leading to a Caspase-Independent Cell Death","volume":"277","author":"Petit","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/373123a0","article-title":"Rapid Turnover of Plasma Virions and CD4 Lymphocytes in HIV-1 Infection","volume":"373","author":"Ho","year":"1995","journal-title":"Nature"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e171554","DOI":"10.1172\/JCI171554","article-title":"The Latent Reservoir of Inducible, Infectious HIV-1 Does Not Decrease despite Decades of Antiretroviral Therapy","volume":"133","author":"McMyn","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s13365-017-0530-3","article-title":"Modeling Brain Lentiviral Infections during Antiretroviral Therapy in AIDS","volume":"23","author":"Roda","year":"2017","journal-title":"J. Neurovirol."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Stefic, K., Chaillon, A., Bouvin-Pley, M., Moreau, A., Braibant, M., Bastides, F., Gras, G., Bernard, L., and Barin, F. (2017). Probing the Compartmentalization of HIV-1 in the Central Nervous System through Its Neutralization Properties. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181680"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s13365-018-0633-5","article-title":"Ultradeep Single-Molecule Real-Time Sequencing of HIV Envelope Reveals Complete Compartmentalization of Highly Macrophage-Tropic R5 Proviral Variants in Brain and CXCR4-Using Variants in Immune and Peripheral Tissues","volume":"24","author":"Brese","year":"2018","journal-title":"J. Neurovirol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"10830","DOI":"10.1128\/JVI.79.16.10830-10834.2005","article-title":"Increased Human Immunodeficiency Virus Type 1 (HIV-1) Env Compartmentalization in the Presence of HIV-1-Associated Dementia","volume":"79","author":"Ritola","year":"2005","journal-title":"J. Virol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"vew020","DOI":"10.1093\/ve\/vew020","article-title":"Compartmentalized HIV Rebound in the Central Nervous System after Interruption of Antiretroviral Therapy","volume":"2","author":"Gianella","year":"2016","journal-title":"Virus Evol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1128\/jvi.68.7.4643-4649.1994","article-title":"Demented and Nondemented Patients with AIDS Differ in Brain-Derived Human Immunodeficiency Virus Type 1 Envelope Sequences","volume":"68","author":"Power","year":"1994","journal-title":"J. Virol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/QAD.0b013e3283299129","article-title":"Cross-Sectional Characterization of HIV-1 Env Compartmentalization in Cerebrospinal Fluid over the Full Disease Course","volume":"23","author":"Harrington","year":"2009","journal-title":"AIDS"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Schnell, G., Joseph, S., Spudich, S., Price, R.W., and Swanstrom, R. (2011). HIV-1 Replication in the Central Nervous System Occurs in Two Distinct Cell Types. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002286"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1073\/pnas.0605513103","article-title":"The HIV Env Variant N283 Enhances Macrophage Tropism and Is Associated with Brain Infection and Dementia","volume":"103","author":"Dunfee","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"a012526","DOI":"10.1101\/cshperspect.a012526","article-title":"HIV Pathogenesis: Dynamics and Genetics of Viral Populations and Infected Cells","volume":"3","author":"Coffin","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1128\/jvi.69.8.5087-5094.1995","article-title":"Lower in Vivo Mutation Rate of Human Immunodeficiency Virus Type 1 than That Predicted from the Fidelity of Purified Reverse Transcriptase","volume":"69","author":"Mansky","year":"1995","journal-title":"J. Virol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1473-3099(13)70066-5","article-title":"Frequency and Implications of HIV Superinfection","volume":"13","author":"Redd","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1089\/aid.2013.0009","article-title":"Dynamics of HIV Type 1 Recombination Following Superinfection","volume":"29","author":"Koning","year":"2013","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrmicro2614","article-title":"Why Do RNA Viruses Recombine?","volume":"9","author":"Holmes","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Feng, Y., Baig, T.T., Love, R.P., and Chelico, L. (2014). Suppression of APOBEC3-Mediated Restriction of HIV-1 by Vif. Front. Microbiol., 5.","DOI":"10.3389\/fmicb.2014.00450"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1073\/pnas.0710190105","article-title":"Cytidine Deamination Induced HIV-1 Drug Resistance","volume":"105","author":"Mulder","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"10133","DOI":"10.1128\/JVI.78.18.10133-10148.2004","article-title":"Independent Evolution of Human Immunodeficiency Virus (HIV) Drug Resistance Mutations in Diverse Areas of the Brain in HIV-Infected Patients, with and without Dementia, on Antiretroviral Treatment","volume":"78","author":"Smit","year":"2004","journal-title":"J. Virol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1086\/315249","article-title":"Antiretroviral Resistance Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Protease from Paired Cerebrospinal Fluid and Plasma Samples","volume":"181","author":"Venturi","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Mohammadzadeh, N., Zhang, N., Branton, W.G., Zghidi-Abouzid, O., Cohen, E.A., Gelman, B.B., Estaquier, J., Kong, L., and Power, C. (2023). The HIV Restriction Factor Profile in the Brain Is Associated with the Clinical Status and Viral Quantities. Viruses, 15.","DOI":"10.3390\/v15020316"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1086\/657342","article-title":"HIV-1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment","volume":"202","author":"Fuchs","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/QAD.0000000000002074","article-title":"Cerebrospinal Fluid Viral Escape in Aviremic HIV-Infected Patients Receiving Antiretroviral Therapy: Prevalence, Risk Factors and Neurocognitive Effects","volume":"33","author":"Ellis","year":"2019","journal-title":"AIDS"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/hiv.13471","article-title":"Cerebrospinal Fluid Virology in People with HIV","volume":"24","author":"Henderson","year":"2023","journal-title":"HIV Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/QAI.0000000000003189","article-title":"Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study","volume":"93","author":"Filippidis","year":"2023","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijid.2019.03.033","article-title":"Symptomatic HIV CNS Viral Escape among Patients on Effective cART","volume":"84","author":"Manesh","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/jcph.612","article-title":"Cerebrospinal Fluid Concentrations of Tenofovir and Emtricitabine in the Setting of HIV-1 Protease Inhibitor-Based Regimens","volume":"56","author":"Lahiri","year":"2016","journal-title":"J. Clin. Pharmacol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/QAI.0000000000001362","article-title":"Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults","volume":"75","author":"Mukerji","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e9969","DOI":"10.1097\/MD.0000000000009969","article-title":"Discordant CSF\/Plasma HIV-1 RNA in Individuals on Virologically Suppressive Antiretroviral Therapy in Western India","volume":"97","author":"Dravid","year":"2018","journal-title":"Medicine"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s13365-013-0148-z","article-title":"Discordant Genotypic Resistance and HIV-1 Genetic Diversity from Paired Plasma and Cerebrospinal Fluid Samples in Chinese Settings","volume":"19","author":"Liu","year":"2013","journal-title":"J. Neurovirol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s15010-019-01268-8","article-title":"Cerebrospinal Fluid Compartmentalization of HIV-1 and Correlation with Plasma Viral Load and Blood-Brain Barrier Damage","volume":"47","author":"Bavaro","year":"2019","journal-title":"Infection"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1086\/650538","article-title":"Discordance between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy","volume":"50","author":"Canestri","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/mi.3.2.90","article-title":"Blood-Brain Barrier Drug Targeting: The Future of Brain Drug Development","volume":"3","author":"Pardridge","year":"2003","journal-title":"Mol. Interv."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s13365-014-0291-1","article-title":"Eradication of Human Immunodeficiency Virus from Brain Reservoirs","volume":"21","author":"Nath","year":"2015","journal-title":"J. Neurovirol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12977-017-0370-5","article-title":"Reduced Antiretroviral Drug Efficacy and Concentration in HIV-Infected Microglia Contributes to Viral Persistence in Brain","volume":"14","author":"Asahchop","year":"2017","journal-title":"Retrovirology"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/QAD.0000000000000951","article-title":"Maraviroc-Intensified Combined Antiretroviral Therapy Improves Cognition in Virally Suppressed HIV-Associated Neurocognitive Disorder","volume":"30","author":"Gates","year":"2016","journal-title":"AIDS"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","article-title":"Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration into the Central Nervous System","volume":"65","author":"Letendre","year":"2008","journal-title":"Arch. Neurol."},{"key":"ref_132","first-page":"45","article-title":"Neurologic Complications of HIV Disease and Their Treatment","volume":"18","author":"Letendre","year":"2010","journal-title":"Top. HIV Med."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Arentoft, A., Troxell, K., Alvarez, K., Aghvinian, M., Rivera Mindt, M., Cherner, M., Van Dyk, K., Razani, J., Roxas, M., and Gavilanes, M. (2022). HIV Antiretroviral Medication Neuropenetrance and Neurocognitive Outcomes in HIV+ Adults: A Review of the Literature Examining the Central Nervous System Penetration Effectiveness Score. Viruses, 14.","DOI":"10.3390\/v14061151"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1080\/09540121.2022.2098231","article-title":"The Effect of Antiretroviral Therapy with High Central Nervous System Penetration on HIV-Related Cognitive Impairment: A Systematic Review and Meta-Analysis","volume":"35","author":"Webb","year":"2022","journal-title":"AIDS Care"},{"key":"ref_135","first-page":"ofz277","article-title":"Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland","volume":"6","author":"Santos","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13365-014-0279-x","article-title":"Treatment Intensification with Maraviroc (CCR5 Antagonist) Leads to Declines in CD16-Expressing Monocytes in cART-Suppressed Chronic HIV-Infected Subjects and Is Associated with Improvements in Neurocognitive Test Performance: Implications for HIV-Associated Neurocognitive Disease (HAND)","volume":"20","author":"Ndhlovu","year":"2014","journal-title":"J. Neurovirol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s13365-017-0600-6","article-title":"CSF Inflammatory Markers and Neurocognitive Function after Addition of Maraviroc to Monotherapy Darunavir\/Ritonavir in Stable HIV Patients: The CINAMMON Study","volume":"24","author":"Barber","year":"2018","journal-title":"J. Neurovirol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/cid\/ciad265","article-title":"Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus","volume":"77","author":"Letendre","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Berruti, M., Riccardi, N., Canetti, D., Lo Caputo, S., Taramasso, L., and Di Biagio, A. (2021). Injectable Antiretroviral Drugs: Back to the Future. Viruses, 13.","DOI":"10.3390\/v13020228"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1016\/S2666-5247(22)00009-X","article-title":"Long-Acting Injectable ART for HIV: A (Cautious) Step Forward","volume":"3","author":"Venkatesan","year":"2022","journal-title":"Lancet Microbe"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/22221751.2020.1713707","article-title":"Broadly Neutralizing Antibodies for HIV-1: Efficacies, Challenges and Opportunities","volume":"9","author":"Liu","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"710044","DOI":"10.3389\/fimmu.2021.710044","article-title":"Can Broadly Neutralizing HIV-1 Antibodies Help Achieve an ART-Free Remission?","volume":"12","author":"Hsu","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"690017","DOI":"10.3389\/fpubh.2021.690017","article-title":"Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic","volume":"9","author":"Spencer","year":"2021","journal-title":"Front. Public Health"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41577-022-00753-w","article-title":"Strategies for HIV-1 Vaccines That Induce Broadly Neutralizing Antibodies","volume":"23","author":"Haynes","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1182\/blood-2002-06-1636","article-title":"Rituximab Therapy for CNS Lymphomas: Targeting the Leptomeningeal Compartment","volume":"101","author":"Rubenstein","year":"2003","journal-title":"Blood"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jha2.338","article-title":"Overview of Approved CAR-T Therapies, Ongoing Clinical Trials, and Its Impact on Clinical Practice","volume":"3","author":"Sengsayadeth","year":"2021","journal-title":"EJHaem"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2251839","DOI":"10.1080\/21645515.2023.2251839","article-title":"Chimeric Antigen Receptor T Cell and Regulatory T Cell Therapy in Non-Oncology Diseases: A Narrative Review of Studies from 2017 to 2023","volume":"19","author":"Sun","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.3389\/fimmu.2019.02711","article-title":"CAR T Cells Beyond Cancer: Hope for Immunomodulatory Therapy of Infectious Diseases","volume":"10","author":"Seif","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.1128\/JVI.00805-16","article-title":"HIV-1-Specific Chimeric Antigen Receptors Based on Broadly Neutralizing Antibodies","volume":"90","author":"Ali","year":"2016","journal-title":"J. Virol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ymthe.2016.12.023","article-title":"Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells","volume":"25","author":"Hale","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Buck, A.M., Deveau, T.-M., Henrich, T.J., and Deitchman, A.N. (2023). Challenges in HIV-1 Latent Reservoir and Target Cell Quantification in CAR-T Cell and Other Lentiviral Gene Modifying HIV Cure Strategies. Viruses, 15.","DOI":"10.3390\/v15051126"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11904-020-00505-2","article-title":"From Berlin to London: HIV-1 Reservoir Reduction Following Stem Cell Transplantation","volume":"17","author":"Prator","year":"2020","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-023-02213-x","article-title":"In-Depth Virological and Immunological Characterization of HIV-1 Cure after CCR5\u039432\/\u039432 Allogeneic Hematopoietic Stem Cell Transplantation","volume":"29","author":"Jensen","year":"2023","journal-title":"Nat. Med."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7326\/M14-1027","article-title":"Antiretroviral-Free HIV-1 Remission and Viral Rebound Following Allogeneic Stem Cell Transplantation: A Report of Two Cases","volume":"161","author":"Henrich","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s13365-021-00947-3","article-title":"Accelerated Epigenetic Aging in Adolescents Living with HIV Is Associated with Altered Development of Brain Structures","volume":"28","author":"Hoare","year":"2022","journal-title":"J. Neurovirol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/QAD.0000000000001854","article-title":"Perinatally Acquired HIV Infection Accelerates Epigenetic Aging in South African Adolescents","volume":"32","author":"Horvath","year":"2018","journal-title":"AIDS"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11904-018-0412-1","article-title":"CNS Persistence of HIV-1 in Children: The Untapped Reservoir","volume":"15","author":"Chahroudi","year":"2018","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Hauser, K.F., Ohene-Nyako, M., and Knapp, P.E. (2023). Accelerated Brain Aging with Opioid Misuse and HIV: New Insights on the Role of Glially Derived pro-Inflammation Mediators and Neuronal Chloride Homeostasis. Curr. Opin. Neurobiol., 78.","DOI":"10.1016\/j.conb.2022.102653"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s11481-020-09941-8","article-title":"Opioid and neuroHIV Comorbidity\u2014Current and Future Perspectives","volume":"15","author":"Fitting","year":"2020","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Trunfio, M., Chaillon, A., Beliakova-Bethell, N., Deiss, R., Letendre, S.L., Riggs, P.K., Higgins, N., and Gianella, S. (2023). Beyond the Syndemic of Opioid Use Disorders and HIV: The Impact of Opioids on Viral Reservoirs. Viruses, 15.","DOI":"10.3390\/v15081712"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/12\/2385\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:33:27Z","timestamp":1760132007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/12\/2385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":160,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["v15122385"],"URL":"https:\/\/doi.org\/10.3390\/v15122385","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,5]]}}}